Diagnosing Gastrointestinal Neuroendocrine Tumors episode artwork

EPISODE · Jun 5, 2009 · 14 MIN

Diagnosing Gastrointestinal Neuroendocrine Tumors

from Medical Breakthroughs from Penn Medicine

Host: Lee Freedman, MD Guest: David Metz, MD Although gastroenteropancreatic neuroendocrine tumors, or GEP-NETs, are relatively common, they are often indolent. However, GEP-NETs can metastasize in a small portion of the population, so physicians should be aware of symptoms and screening tools. The two most common types of GEP-NETs are categorized as carcinoids and pancreatic endocrine tumors. What distinguishes the two? Host Dr. Lee Freedman welcomes Dr. David Metz, professor of medicine and associate chief for clinical affairs in the division of gastroenterology at Penn Medicine, to discuss characteristics and diagnosis of GEP-NETs. Produced in Cooperation with

Episode metadata supplied by the publisher feed · Published Jun 5, 2009

Embed this episode

NOW PLAYING

Diagnosing Gastrointestinal Neuroendocrine Tumors

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Breakthroughs from Penn Medicine?

This episode is 14 minutes long.

When was this Medical Breakthroughs from Penn Medicine episode published?

This episode was published on June 5, 2009.

Can I download this Medical Breakthroughs from Penn Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!